Annals of Diagnostic Pathology
Volume 11, Issue 3 , Pages 228-234 , June 2007

Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions

This review article was presented in the Surgical Pathology Update at Leipzig, Germany on June 14, 2007.

References 

  1. Shih IM. Gestational trophoblastic neoplasms–Pathogenesis and target-based therapy. Lancet Oncology. 2000;[in press]
  2. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31–47
  3. Shih IM, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol. 1999;30:687–694
  4. Shih I-M, Kurman RJ. Epithelioid trophoblastic tumor—a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22:1393–1403
  5. Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176–187
  6. Mao TL, Kurman RJ, Huang CC, et al. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007;[in press]
  7. Oldt RJ, Kurman RJ, Shih Ie M. Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol. 2002;161:1033–1037
  8. Shih IM, Kurman RJ. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004;28:1177–1183
  9. Shih I-M, Kurman RJ. Molecular basis of gestational trophoblastic diseases. Curr Mol Med. 2002;2:1–12
  10. Shih I-M, Mazur MT, Kurman RJ. Gestational trophoblastic disease. In:  Kurman RJ editors. Blaustein's pathology of the female genital tract. 5th. New York: Springer-Verlag; 2002;p. 1193–1247
  11. Chang YL, Chang TC, Hsueh S, et al. Prognostic factors and treatment for placental site trophoblastic tumor—report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73:216–222
  12. Shih IM, Kurman RJ. Placental site trophoblastic tumor—past as prologue. Gynecol Oncol. 2001;82:413–414
  13. Shih IM, Kurman RJ. Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest. 1996;75:377–388
  14. Simard J, Ricketts ML, Gingras S, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev. 2005;26:525–582
  15. Mao T, Kurman R, Jeng Y. et al. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumor-like lesions [unpublished].
  16. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305–316
  17. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002;18:90–95
  18. Little NA, Jochemsen AG. p63. Int J Biochem Cell Biol. 2002;34:6–9
  19. Patturajan M, Nomoto S, Sommer M, et al. DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell. 2002;1:369–379
  20. Kurman RJ, Young RH, Norris HJ, et al. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol. 1984;3:101–121
  21. Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23:7212–7220
  22. Shih IM, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol. 1998;29:27–33
  23. Koff A, Cross F, Fisher A, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 1991;66:1217–1228
  24. Ohtsubo M, Theodoras AM, Schumacher J, et al. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15:2612–2624
  25. Lin LPM, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, et al. Identification and characterization of a 192 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res. 2000;60:7021–7027
  26. Nakayama K, Nakayama N, Jinawath N, et al. Amplicon profiles in ovarian serous carcinomas. Int J Cancer. 2007;120:2613–2617
  27. Bamberger AM, Aupers S, Milde-Langosch K, Loning T. Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67. Int J Gynecol Pathol. 2003;22:156–161
  28. Mao TL, Seidman JD, Kurman RJ, Shih Ie M. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor—an aid in differential diagnosis. Am J Surg Pathol. 2006;30:1105–1110

PII: S1092-9134(07)00050-0

doi: 10.1016/j.anndiagpath.2007.04.001

Annals of Diagnostic Pathology
Volume 11, Issue 3 , Pages 228-234 , June 2007

Article Tools

* Image Usage & Resolution